The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of tumor and circulating cell free (cf) DNA mutations in women with hormone refractory metastatic breast cancer (MBC) enrolled in a phase I study of Z-Endoxifen (MC093C).
 
Matthew P. Goetz
Consulting or Advisory Role - Lilly (Inst)
Research Funding - Lilly; Pfizer
 
Vera J. Suman
No Relationships to Disclose
 
Joel M. Reid
No Relationships to Disclose
 
Donald W. Northfelt
No Relationships to Disclose
 
Sarah A Burhow
No Relationships to Disclose
 
Stephanie L. Safgren
No Relationships to Disclose
 
Renee M. McGovern
No Relationships to Disclose
 
Travis J. Dockter
No Relationships to Disclose
 
Tufia C. Haddad
No Relationships to Disclose
 
Charles Erlichman
No Relationships to Disclose
 
Alex A. Adjei
No Relationships to Disclose
 
Daniel W. Visscher
Patents, Royalties, Other Intellectual Property - Mayo Clinic (Inst)
 
Benjamin Kipp
Research Funding - Abbott Molecular
Patents, Royalties, Other Intellectual Property - Abbott Molecular
 
John Hawse
No Relationships to Disclose
 
James H. Doroshow
No Relationships to Disclose
 
Jerry M. Collins
No Relationships to Disclose
 
Howard Streicher
No Relationships to Disclose
 
Matthew M. Ames
No Relationships to Disclose
 
James N. Ingle
No Relationships to Disclose
 
Minetta C. Liu
Research Funding - Celgene (Inst); Eisai (Inst); GRAIL (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Veridex (Inst)
Travel, Accommodations, Expenses - Celgene; GRAIL; Merck